Literature DB >> 25254421

Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells.

Qiang Bai1, Jean-Marie Ramirez, Fabienne Becker, Véronique Pantesco, Thierry Lavabre-Bertrand, Outi Hovatta, Jean-Marc Lemaître, Franck Pellestor, John De Vos.   

Abstract

Simplified culture conditions are essential for large-scale drug screening and medical applications of human pluripotent stem cells (hPSCs). However, hPSCs [ie, human embryonic stem cells (hESCs), and human induced pluripotent stem cells (iPSCs) are prone to genomic instability, a phenomenon that is highly influenced by the culture conditions. Enzymatic dissociation, a cornerstone of large-scale hPSC culture systems, has been reported to be deleterious, but the extent and the timeline of the genomic alterations induced by this passaging technique are still unclear. We prospectively monitored three hESC lines that were initially derived and cultured on human feeders and passaged mechanically before switching to enzymatic single-cell passaging. We show that karyotype abnormalities and copy number variations are not restricted to long-term culture, but can occur very rapidly, within five passages after switching hESCs to enzymatic dissociation. Subchromosomal abnormalities preceded or accompanied karyotype abnormalities and were associated with increased occurrence of DNA double-strand breaks. Our results indicate that enzymatic single-cell passaging can be highly deleterious to the hPSC genome, even when used only for a limited period of time. Moreover, hPSC culture techniques should be reappraised by complementing the routine karyotype analysis with more sensitive techniques, such as microarrays, to detect subchromosomal abnormalities.

Entities:  

Mesh:

Year:  2014        PMID: 25254421      PMCID: PMC4333508          DOI: 10.1089/scd.2014.0292

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  45 in total

1.  Preserving the genetic integrity of human embryonic stem cells.

Authors:  Maisam M Mitalipova; Raj R Rao; Deborah M Hoyer; Julie A Johnson; Lorraine F Meisner; Karen L Jones; Stephen Dalton; Steven L Stice
Journal:  Nat Biotechnol       Date:  2005-01       Impact factor: 54.908

2.  ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells.

Authors:  Xiangyun Li; Roman Krawetz; Shiying Liu; Guoliang Meng; Derrick E Rancourt
Journal:  Hum Reprod       Date:  2008-12-04       Impact factor: 6.918

3.  Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors:  Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal:  Nat Biotechnol       Date:  2008-11-23       Impact factor: 54.908

4.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

5.  Recurrent copy number variations in human induced pluripotent stem cells.

Authors:  Kristen Martins-Taylor; Benjamin S Nisler; Seth M Taapken; Tiwanna Compton; Leann Crandall; Karen Dyer Montgomery; Marc Lalande; Ren-He Xu
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

6.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

7.  Human embryonic fibroblasts support single cell enzymatic expansion of human embryonic stem cells in xeno-free cultures.

Authors:  Mark Kibschull; Maria Mileikovsky; Iacovos P Michael; Stephen J Lye; Andras Nagy
Journal:  Stem Cell Res       Date:  2010-08-27       Impact factor: 2.020

8.  Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.

Authors:  Jeanette Beers; Daniel R Gulbranson; Nicole George; Lauren I Siniscalchi; Jeffrey Jones; James A Thomson; Guokai Chen
Journal:  Nat Protoc       Date:  2012-10-25       Impact factor: 13.491

9.  Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL.

Authors:  H T Nguyen; M Geens; A Mertzanidou; K Jacobs; C Heirman; K Breckpot; C Spits
Journal:  Mol Hum Reprod       Date:  2013-11-11       Impact factor: 4.025

10.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

View more
  27 in total

Review 1.  Direct somatic lineage conversion.

Authors:  Koji Tanabe; Daniel Haag; Marius Wernig
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

2.  Simultaneous reprogramming and gene editing of human fibroblasts.

Authors:  Sara E Howden; James A Thomson; Melissa H Little
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

3.  Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.

Authors:  Elke Gabriel; Jay Gopalakrishnan
Journal:  J Vis Exp       Date:  2017-04-14       Impact factor: 1.355

4.  Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells.

Authors:  Junjie Lu; Hu Li; Anna Baccei; Takayo Sasaki; David M Gilbert; Paul H Lerou
Journal:  Stem Cells Dev       Date:  2016-04-11       Impact factor: 3.272

Review 5.  Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.

Authors:  Clara Steichen; Zara Hannoun; Eléanor Luce; Thierry Hauet; Anne Dubart-Kupperschmitt
Journal:  World J Stem Cells       Date:  2019-10-26       Impact factor: 5.326

6.  Rapid and Highly Efficient Isolation and Purification of Human Induced Pluripotent Stem Cells.

Authors:  Xiugong Gao; Robert L Sprando; Jeffrey J Yourick
Journal:  Methods Mol Biol       Date:  2022

7.  Generating Loss-of-function iPSC Lines with Combined CRISPR Indel Formation and Reprogramming from Human Fibroblasts.

Authors:  Andrew M Tidball; Preethi Swaminathan; Louis T Dang; Jack M Parent
Journal:  Bio Protoc       Date:  2018-04-05

8.  A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types.

Authors:  Carol X-Q Chen; Narges Abdian; Gilles Maussion; Rhalena A Thomas; Iveta Demirova; Eddie Cai; Mahdieh Tabatabaei; Lenore K Beitel; Jason Karamchandani; Edward A Fon; Thomas M Durcan
Journal:  Methods Protoc       Date:  2021-07-19

9.  CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells.

Authors:  Rowan Flynn; Alexander Grundmann; Peter Renz; Walther Hänseler; William S James; Sally A Cowley; Michael D Moore
Journal:  Exp Hematol       Date:  2015-06-19       Impact factor: 3.084

Review 10.  Induced Pluripotent Stem Cell Therapies for Degenerative Disease of the Outer Retina: Disease Modeling and Cell Replacement.

Authors:  Valentina Di Foggia; Priyanka Makwana; Robin R Ali; Jane C Sowden
Journal:  J Ocul Pharmacol Ther       Date:  2016-03-30       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.